Refractory Lymphoblastic Leukemia, Acute, Childhood
Also known as: Refractory Childhood Acute Lymphoblastic Leukemia
Drug | Drug Name | Drug Description |
---|---|---|
DB00444 | Teniposide | A cytotoxic drug used as an adjunct for chemotherapy induction in the treatment of refractory childhood acute lymphoblastic leukemia. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01254 | Dasatinib | 1 | Terminated | 1 |
DB06132 | Nivolumab | 1 | Terminated | 1 |
DB09035 | Nivolumab | 1 | Terminated | 1 |
DB17364 | AUTO3 | 1 / 2 | Completed | 1 |
DB01073 | Fludarabine | 2 | Completed | 1 |
DB16620 | Methopterin | 2 | Completed | 1 |
DB00563 | Methotrexate | 2 | Completed | 1 |
DB00864 | Tacrolimus | 2 | Completed | 1 |
DB04572 | Thiotepa | 2 | Completed | 1 |
DB03754 | Tromethamine | 2 | Completed | 1 |